Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: JT Note - FWIW
I would believe that these settlements are for more dollars than this company has realized in the past.  How this does not constitute a "material event" for reporting purposes is something Turley should have to address.  There are SEC rules that he is required to follow.  I am at a loss as to what logic PTSC's Attorney is using to say this is not a material event.  Then again the Attorney at the SHM would not let Turley answer the question as to Turley's view of the validity of the patents.  I understand the need for confidentiality, but all parties but TPL are going to have to disclose the numbers.  Couldn't be happier with the results, however to get the share price to the level we all want, the Company has to disclose the numbers associated with each deal.
Share
New Message
Please login to post a reply